Current Ratio of Inozyme Pharma, Inc. from 31 Mar 2021 to 31 Mar 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Inozyme Pharma, Inc. quarterly Current Ratio in % history and change rate from 31 Mar 2021 to 31 Mar 2025.
  • Inozyme Pharma, Inc. Current Ratio for the quarter ending 31 Mar 2025 was 460%, a 67% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Inozyme Pharma, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q1 2025 460% -930% -67% 31 Mar 2025
Q4 2024 734% -573% -44% 31 Dec 2024
Q3 2024 1090% -91% -7.7% 30 Sep 2024
Q2 2024 1319% +262% +25% 30 Jun 2024
Q1 2024 1390% +282% +25% 31 Mar 2024
Q4 2023 1307% +258% +25% 31 Dec 2023
Q3 2023 1181% +98% +9% 30 Sep 2023
Q2 2023 1057% -95% -8.3% 30 Jun 2023
Q1 2023 1108% -116% -9.5% 31 Mar 2023
Q4 2022 1049% -507% -33% 31 Dec 2022
Q3 2022 1083% -661% -38% 30 Sep 2022
Q2 2022 1152% -646% -36% 30 Jun 2022
Q1 2022 1225% -358% -23% 31 Mar 2022
Q4 2021 1556% 31 Dec 2021
Q3 2021 1744% 30 Sep 2021
Q2 2021 1798% 30 Jun 2021
Q1 2021 1582% 31 Mar 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.